Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group

• Published in: Circulation (New York, N.Y.) Vol. 88; no. 3; pp. 975 - 985
• Main Authors: Rensing, B J, Hermans, W R, Vos, J, Tijssen, J G, Rutch, W, Danchin, N, Heyndrickx, G R, Mast, E G, Wijns, W, Serruys, P W
• Format: Journal Article
• Language: English
• Published: United States 01.09.1993
• Subjects: Angioplasty, Balloon, Coronary; Biphenyl Compounds - therapeutic use; Coronary Angiography; Coronary Disease - diagnostic imaging; Coronary Disease - epidemiology; Coronary Disease - therapy; Female; Follow-Up Studies; Heptanoic Acids - therapeutic use; Humans; Male; Middle Aged; Receptors, Thromboxane - antagonists & inhibitors; Recurrence; Regression Analysis; Risk Factors; Time Factors

The renarrowing process after successful percutaneous transluminal coronary angioplasty (PTCA) is now believed to be caused by a response-to-injury vessel wall reaction. The magnitude of this process can be assessed by the change in minimal lumen diameter (MLD) at follow-up angiography. The aim of t...